The trials of the Oxford COVID-19 vaccine candidate were halted world over after one volunteer developed 'unexplained illness'
17 Sep 2020 12:32 PM
Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine
11 Sep 2020 1:15 PM
DGCI sought an immediate reply, saying else "it shall be construed that you have no explanation to offer and action will be taken"
10 Sep 2020 10:29 AM
AstraZeneca is one of nine companies currently in late-stage Phase 3 trials for their COVID-19 vaccine candidates
09 Sep 2020 8:51 AM
The vaccine trials are being conducted by the Serum Institute of India in Pune
27 Aug 2020 12:29 PM
Anticipating a backlash from vocal anti-vaccine activists, Morrison said the stakes were too high to allow the disease to continue unchecked
20 Aug 2020 1:22 PM
UK government reserved one fill-and-finish production line at Wockhardt subsidiary in Wrexham, Wales for exclusive use for next 18 months
03 Aug 2020 4:27 PM
Oxford University and AstraZeneca announced their vaccine's success in inducing immune responses in volunteers without causing side effects
21 Jul 2020 1:37 PM
The first human trial of the vaccine, a month-long test on 38 people, ended this week, and Phase III trial is set to begin in August
16 Jul 2020 8:26 PM
Rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first
18 Jun 2020 12:01 PM
Gilead, AstraZeneca and several other drugmakers are racing to develop vaccines for COVID-19
07 Jun 2020 4:06 PM
Shares of Sun Pharma rose as much as 5.4 per cent to a nine-week high after the announcement.
06 Nov 2019 12:49 PM
Given as a maintenance therapy to reinforce initial chemotherapy, Lynparza halted or reversed tumour growth in 60 percent of patients.
22 Oct 2018 8:54 AM
The shares surged over 7 per cent after the company entered into a pact.
01 Jun 2017 12:36 PM